Receptors for kinins: From classical pharmacology to molecular biology

Immunopharmacology

Volumn 33, Issue 1-3, 1996, Pages 116-122

  Regoli, D ^a   Pheng, L H ^a   Allogho, S Nsa ^a   Nguyen Le, X K ^a   Gobeil, F ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

B1 receptor; B2 receptor; bradykinin; endothelium; isolated vessel; smooth muscle

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR AGONIST; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO PHENYLALANINE]; ICATIBANT; KALLIDIN; NITRIC OXIDE; PROSTANOID; [[4 [2 [[BIS(CYCLOHEXYLAMINO)METHYLENE]AMINO] 3 (2 NAPHTHYL)PROPIONAMIDO]PHENYL]METHYL]TRIBUTYLPHOSPHONIUM CHLORIDE;

ANIMAL TISSUE; AORTA; CAROTID ARTERY; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DOG; HUMAN; HUMAN TISSUE; JUGULAR VEIN; KIDNEY ARTERY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0030176046     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(96)00025-2     Document Type: Conference Paper

References (32)

1. Altura BM, Chond N. Bradykinin-induced relaxation of renal and pulmonary arteries is dependent upon intact endothelial cells. Br J Pharmacol 1981; 74: 10-11.
2. Barabé J, Marceau F, Thériault B, Drouin JN, Regoli D. Cardiovascular actions of kinins in the rabbit. Can J Physiol Pharmacol 1978; 57: 78-91.
3. Beny JL, Von der Weid PY. Hydrogen peroxide an endogenous smooth muscle cell hyperpolarizing factor. Biochem Biophys Res Commun 1991; 176: 378-384.
4. Couture R, Gaudreau P, St-Pierre S, Regoli D. The dog carotid artery: a sensitive bioassay for studying vasodilator effects of substance P and of kinins. Can J Physiol Pharmacol 1980; 58: 1234-1244.
5. Félétou M, Martin CAE, Molimard M, Naline E, Germain M, Thuriau C, Fauchère JL, Canet E, Advenier C. In vitro effects of HOE 140 in human bronchial and vascular tissue. Eur J Pharmacol 1995; 274: 57-64.
6. Furchgott RF. The requirements for endothelial cells in the relaxation of arteries by acetylcholine and some other vasodilators. Trends Pharmacol Sci 1981; 3: 173-175.
7. Furchgott RF, Bhadrakom S. Reactions of strips of rabbit aorta to epinephrine. isoproterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther 1953: 108: 129-143.
8. Gaudreau P, Barabé, J, St-Pierre S, Regoli D. Pharmacological studies of kinins in venous smooth muscles. Can J Physiol Pharmacol 1981; 59: 371-379.
9. Gobeil F, Pheng LH, Badinin I, Xguyen-Le XK, Pizard A, Rizzi A, Blouin D, Regoli D. Receptors for kinins in human isolated umbilical vein. Br J Pharmacol (in press).
10. 2 bradykinin receptors. Mol Pharmacol 1994; 45: 1-8.
11. Hess JF, Borkowski JA, Young GS, Strader CD, Ramson RW. Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor. Biochem Biophys Res Commun 1992; 184: 260-268.
12. Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, König W, Knolle J, Schölkens BA. HOE 140, a new potent and long-acting bradykinin antagonist: in vitro studies. Br J Pharmacol 1992; 102: 769-773.
13. Horton EW. The estimation of human kallkrein. J Physiol (Lond) 1959; 148: 267-282.
14. 1 receptor. Biochim Biophys Acta 1995; 1264: 223-228.
15. 2 receptors on the venoconstriction action of bradykinin. J Pharmacol Exp Ther 1994; 269: 1136-1143.
16. Menke JG, Borkowski JA, Bierilo XK, McNeil T. Derrick AW, Schneck KA, Ransom RW, Strader CD, Linesneyer DL, Hess JF. Expression and cloning of a human B-I bradykinin receptor. J Biol Chem 1994; 269: 21583-21586.
17. Mombouli JV, Illiano S, Nagao T, Vanhoutte PM. The potentiation of bradykinin-induced relaxations by perindoprilat in canine coronary arteries involves both nitric oxide and endothelium derived hyperpolarizing factor. Circ Res 1992; 71: 137-144.
18. Moncada S, Plamer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
19. Regoli D, Barabé J. Kinin receptors. Methods Enzymol 1980a; 163: 210-230.
20. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980b; 32: 1-46.
21. Regoli D, Barabé J. Park WK. Receptors for bradykinin in rabbit aortae. Can J Physiol Pharmacol 1977; 55: 855-867.
22. 2 subtypes. Life Sci 1994; 10: 735-749.
23. Regoli D, Jukic D, Gobeil F, Rhaleb NE. Receptors for bradykinin and related kinins: a critical analysis. Can J Physiol Pharmacol 1993; 71: 556-567.
24. Regoli D, Marceau F, Barabé J. De novo formation of vascular receptors for bradykinin. Can J Physiol Pharmacol 1978; 56: 674-677.
25. Regoli D, Mizrahi J, D'Orléans-Juste P, Caranikas S. Effects of kinins on isolated vessels. Role of endothelium. Can J Physiol Pharmacol 1982; 60: 1580-1583.
26. Rhaleb NE, Dion S, Barabé, J. Rouissi N, Jukic D Drapeau G, Regoli D. Receptors for kinins in isolated arterial vessels of dogs. Eur J Pharmacol 1989; 162: 419-427.
27. Rocha e Silva M. Kinin Hormones. Springfield, IL: CC Thomas, 1970.
28. 2 receptor J Med Chem 1993; 36: 2583-2584.
29. Schild HO. pA, a new scale for the measurement of drug antagonism. Br J Pharmacol 1947; 2: 189-206.
30. 2 bradykinin antagonists. In: Burch RM. Ed. Bradykinin Antagonists. New York, Marcel Dekker, 1991; 51-96.
31. Trautschold I. Assay methods in the kinin system. Handb Exp Pharmacol 1970; 25: 52-81.
32. Vavrek RJ, Stewart JM. Competitive antagonists of bradykinin. Peptides 1985; 6: 161-164.